<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01916005</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00056-39</org_study_id>
    <secondary_id>2013-01</secondary_id>
    <nct_id>NCT01916005</nct_id>
  </id_info>
  <brief_title>Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis</brief_title>
  <official_title>Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The diagnosis of prosthetic valve endocarditis (PVE) remains challenging. In PVE cases,
      initial echocardiography is normal or inconclusive in almost 30% of cases, leading to a
      decreased diagnostic accuracy for the modified Duke criteria.

      Aims: The investigators sought to determine the value of 18F-fluorodeoxyglucose positron
      emission tomography/computed tomography (18F-FDG PET/CT) for diagnosing PVE.

      Methods: In two referral French centers (Timone Hospial, Marseille and Georges Pompidou
      European Hospital, Paris), the investigators plan to include consecutive patients suspected
      of having PVE. All of the patients will be subjected to clinical, microbiological, and
      echocardiographic evaluation. Cardiac PET/CT will be performed at admission and the data
      analysis will be based on visual interpretation and quantitative measurement of FDG uptake
      (SUVmax). The final diagnosis will be defined according to the clinical and/or pathological
      modified Duke criteria determined during a 3-month follow-up (gold standard).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the diagnosis of prosthetic valve infective endocarditis</measure>
    <time_frame>39months</time_frame>
    <description>18F-fluorodeoxyglucose positron emission tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the reproducibility of the technique,</measure>
    <time_frame>39 months</time_frame>
    <description>the other diagnostic parameters of PET/CT (specificity and predictive values)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the comparison of the sensitivity of PET/CT with that of echocardiography,</measure>
    <time_frame>39 MONTHS</time_frame>
    <description>the other diagnostic parameters of PET/CT (specificity and predictive values)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of detection of embolic events,</measure>
    <time_frame>39 MONTHS</time_frame>
    <description>the other diagnostic parameters of PET/CT (specificity and predictive values)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the prognostic value of the technique (death/valve surgery)</measure>
    <time_frame>39 MONTHS</time_frame>
    <description>the other diagnostic parameters of PET/CT (specificity and predictive values)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Prosthetic Valve Endocarditis (PVE)</condition>
  <arm_group>
    <arm_group_label>endocarditis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>18F-FDG PET/CT</intervention_name>
    <arm_group_label>endocarditis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unexplained persistent or recurrent fever &gt;38Â°C;

          -  and/or unexplained increased serum C-reactive protein (CRP) level &gt;10 mg/L; and/or
             positive blood cultures, independent of the echocardiographic analysis results;

          -  and/or positive serological testing for Coxiella burnetii, Bartonella spp., Mycoplasma
             pneumoniae, Legionella pneumophila, Aspergillus spp., or Tropheryma whipplei;

          -  and/or a mass or a new partial prosthetic valve dehiscence observed using
             echocardiography.

        Exclusion Criteria:

          -  pregnancy,

          -  an inability to lie flat,

          -  a need for urgent cardiac surgery,

          -  hemodynamic instability,

          -  cardiac surgery &lt;1 month ago,

          -  and a blood glucose level &gt;1.8 g/L. Patients with a poor PET/CT image quality
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LOIC MONDOLONI</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>FRANCK THUNY</last_name>
    <email>franck.thuny@aphm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>franck thuny</last_name>
      <email>franck.thuny@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>franck THUNY</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2013</study_first_posted>
  <last_update_submitted>August 21, 2015</last_update_submitted>
  <last_update_submitted_qc>August 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endocarditis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
    <mesh_term>Deoxyglucose</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

